Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 25 - Aug 30
The First 24 to 72 Hours Most people notice the onset of nausea within the first day of their first injection
But healthcare providers are excited about the possibility of having one more treatment option for people with these conditionsprovided you need a GLP-1 in the first place
Product Features Name: Retatrutide Concentration: 20 mg Form: Lyophilized (freeze-dried) powder Purity: 99% (HPLC verified) Molecular formula: CHNO Molecular weight: ~6473.2 g/mol CAS number: 2381089-83-2 Receptor activity: GLP-1 / GIP / GCGR agonist Applications in research Retatrutide is widely used in research projects aimed at: The role of incretin hormones in metabolic processes Energy consumption and fat metabolism Regulation of appetite and satiety mechanisms Innovative strategies within metabolic and endocrine research Packaging and storage Contents: 1 vial of Retatrutide 20 mg Storage advice: Store in a cool, dry place (2-8 C), protected from light Why choose Retatrutide 20 mg
Report suspected adverse effects via the MHRA Yellow Card scheme and dispose of used needles in NHS-approved sharps containers
Keep a menstrual diary documenting cycle length, duration of bleeding, and heaviness (number of sanitary products used)
